Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

15:38 IST BSE
Debt & BorrowingKesar Enterprises Ltd KESARENT

Kesar Enterprises Debt & Borrowing: ₹59.25 Cr

Kesar Enterprises Limited (BSE: 507180) confirmed it does not meet the SEBI criteria for classification as a 'Large Corporate' as of March 31, 2026. The company reported total outstanding borrowings of ₹59.25 Crore and a credit rating of 'D' from CARE Ratings. Consequently, the SEBI debt-sourcing framework is not applicable to the company for the upcoming period.

Value
₹59.25 Cr
15:36 IST NSE
Fund Raise5Paisa Capital Ltd 5PAISA

5Paisa Capital Fund Raise of ₹150 Cr

5paisa Capital Limited certified the full utilization of proceeds from Commercial Papers issued and listed on the NSE during Q4 FY2026. The company utilized ₹150 Crore raised through various CP series for disclosed purposes while maintaining compliance with SEBI listing conditions. Most instruments listed have been redeemed, with one series pending maturity in June 2026.

Value
₹150.0 Cr
15:38 IST BSE
Debt & BorrowingKwality Pharmaceuticals Ltd KPL

Kwality Pharmaceuticals Debt & Borrowing: ₹28.47 Cr

Kwality Pharmaceuticals Ltd confirmed it does not meet the SEBI criteria for identification as a Large Corporate as of March 31, 2026. The company reported outstanding borrowings of ₹28.47 Crore and maintains a BBB credit rating from ICRA Limited. This disclosure is a routine regulatory compliance filing regarding debt-raising frameworks.

Value
₹28.47 Cr
15:35 IST BSE
Financial ResultsAdani Enterprises Ltd ADANIENT

Adani Enterprises Financial Results

Adani Enterprises Ltd reported consolidated total income of ₹1,02,943.24 Crore and net profit of ₹9,950.69 Crore for FY2025-26. The board recommended a final dividend of ₹1.30 per share and approved a fundraise of up to ₹15,000 Crore through equity issuance. Ernst & Young LLP was appointed as the new Internal Auditor.

Value
₹1,02,943 Cr
15:33 IST BSE
Merger & RestructuringLaurus Labs Ltd LAURUSLABS

Laurus Labs Merger & Restructuring Worth ₹107.8 Cr

Laurus Labs approved an additional investment of approximately ₹107.80 Crore (EURO 9.8 million) in its joint venture, KRKA Pharma Private Limited. The funds will support KRKA's capital expenditure for setting up a manufacturing facility. The company's shareholding in the JV will remain unchanged at 49%.

Value
₹107.8 Cr
Execution
Financial year 2026-27
15:33 IST BSE
Board Meeting DateSavita Oil Technologies Ltd SOTL

Savita Oil Technologies Board Meeting Date

Savita Oil Technologies Ltd will hold a board meeting on May 7, 2026, to consider Q4 and FY26 audited financial results. The board will also discuss a final dividend for FY 2025-26 and a scheme of amalgamation with its wholly-owned subsidiary, Savita GreenTec Limited. The trading window remains closed until 48 hours post-result disclosure.

15:32 IST BSE
Other AnnouncementBhatia Communications & Retail (India) Ltd BHATIA

Bhatia Communications & Retail (India) Other Announcement

Bhatia Communications & Retail (India) Ltd has filed its Annual Secretarial Compliance Report for FY2026. The report, issued by Practicing Company Secretary Bhaveshkumar Rawal, notes minor past disclosure inconsistencies regarding a GST litigation and premium components in promoter share allotments, which have since been rectified or disclosed.

15:32 IST BSE
Debt & BorrowingRLF Ltd RLF

RLF Debt & Borrowing

RLF Limited announced that it does not meet the criteria for a 'Large Corporate' as of March 31, 2026, under SEBI regulations. The company's outstanding long-term borrowings remain below the Rs. 1,000 Crore threshold. Consequently, the specific debt-raising and disclosure requirements for Large Corporates are not applicable for the financial year.

15:31 IST BSE
AcquisitionKopran Ltd KOPRAN

Kopran Acquisition

Kopran Limited announced meetings for shareholders and creditors on June 03, 2026, to approve the merger by absorption of Kopran Laboratories Limited. The amalgamation is pursuant to an NCLT Mumbai Bench order dated April 09, 2026. This consolidation aims to merge the transferor entity into the transferee company.